Pharma BD Deal Intelligence
Outcome grade pending — assessed 5 years post-close.
Full analysis, sources & comparables →We expect to benefit from Binax's established reputation in respiratory diagnostics, and we are excited about the potential new product development…
On March 31, 2005, Inverness Medical Innovations completed its acquisition of Binax pursuant to an Agreement and Plan of Merger dated February 8,…
Abbott closed the Alere acquisition at the reduced price of $5.3 billion on October 3, 2017.
Source summaries from our enrichment pipeline; follow links for originals.
All 5 sources with sentiment breakdown →
1.4M Inverness shares + $8.8M cash; rapid diagnostics for infectious disease
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Inverness Medical Innovations Inc. / Binax Inc. (this deal) | 2004 | — | — |
| Inverness Medical Innovations Inc. / Abbott Laboratories Rapid Diagnostics (pregnancy / drug-of-abuse lines) | 2003 | $92M | 71 |
| Inverness Medical Innovations Inc. / Innogenetics Diagnostica y Terapeutica S.A. (IDT) | 2005 | $19M | 45 |
| Inverness Medical Innovations Inc. / Ischemia Technologies Inc. | 2004 | $22M | 33 |
| Inverness Medical Innovations Inc. / Thermo BioStar, Inc. | 2005 | $52M | 31 |
| UCB SA / Celltech Group plc | 2004 | $2.7B | 92 |
| Yamanouchi Pharmaceutical / Fujisawa Pharmaceutical Co. Ltd. | 2004 | $7.6B | 84 |